[Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl)]. 1978

G Tomei, and G Mosti, and M Veltri, and C Giusti

The effect on the exercise tolerance induced by a new selective beta1-receptor antagonist, metoprolol, given by a single administration per os, has been evaluated in 16 patients with stable angina pectoris. The study was a double blind cross-over between metoprolol 100 mg and placebo. Patients were hospitalized for the time required for the performance of the study; every cardioactive drug, except for trinitrine, was stopped 72 hours prior to the study period. Exercise testing was performed two hours after the intake of the drug, in a sitting position on a bicycle ergometer; the workload was increased by 25 Watts increments every two minutes. Compared to placebo, the total workload performed and duration of exercise increased after metoprolol (P less than 0.001), heart rate decreased (P less than 0.001) both in the resting state and during exercise test, systolic blood pressure didn't change in the resting state but decreased during exercise test (P less than 0.01), pressure-rate product, an useful index of changes in myocardial oxygen consumption decreased both in the resting state (P less than 0.001) and during exercise test (P less than 0.001). It is concluded that metoprolol induces a significant increase in exercise tolerance. This is due to a marked reduction in oxygen myocardial consumption resulting by both decreased heart rate and systolic pressure.

UI MeSH Term Description Entries
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions

Related Publications

G Tomei, and G Mosti, and M Veltri, and C Giusti
January 1979, Giornale italiano di cardiologia,
G Tomei, and G Mosti, and M Veltri, and C Giusti
January 1981, Giornale italiano di cardiologia,
G Tomei, and G Mosti, and M Veltri, and C Giusti
May 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
G Tomei, and G Mosti, and M Veltri, and C Giusti
July 1984, Japanese heart journal,
G Tomei, and G Mosti, and M Veltri, and C Giusti
January 1980, British journal of clinical practice. Supplement,
G Tomei, and G Mosti, and M Veltri, and C Giusti
July 1971, The American journal of medicine,
G Tomei, and G Mosti, and M Veltri, and C Giusti
February 1975, European journal of clinical pharmacology,
G Tomei, and G Mosti, and M Veltri, and C Giusti
October 1988, Vnitrni lekarstvi,
G Tomei, and G Mosti, and M Veltri, and C Giusti
July 1978, Chest,
G Tomei, and G Mosti, and M Veltri, and C Giusti
December 1989, The Tokushima journal of experimental medicine,
Copied contents to your clipboard!